Antidepressant fluvoxamine may cut COVID-19 hospitalisation risk
WorldTags: Print EditionFRANCE: Treating high-risk COVID-19 patients with the antidepressant fluvoxamine may reduce the risk of prolonged hospitalisation by up to a third, a large-scale study showed Thursday (Oct 28).
Authors said the…
Read More...
Read More...
